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Abstract
Enterococci are among the major pathogens implicated in cardiac infections and biofilm formation. E. faecalis has been
shown to play an important role in infectious endocarditis. Several distinct mechanisms for biofilm formation have been
identified in E. faecalis. Our group has previously characterized two distinct bacterial glucosyltransferases playing key roles
in the production of the major cell wall glycolipids and leading to reduced biofilm production. To assess if this mechanism is
involved in the pathogenesis of enterococcal endocarditis we compared the wild-type strain of E. faecalis 12030 with two
mutants in gene EF2891 and EF2890 respectively in a rat model of infective endocarditis. The results showed less
endocarditic lesions and reduced colony counts per vegetation in the two mutants. indicating that the modification of
bacterial surface lipids results in significantly reduced virulence in infective endocarditis. These results underscore the
important role of biofilm formation in the pathogenicity of enterococcal endocarditis and may indicate an interesting target
for novel therapeutic strategies.
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Introduction
The number of multidrug resistant bacteria has increased
steadily over the past decades, and the associated problems gain
more and more importance with regard to infections, especially in
hospitalized patients. Every year the number of patients dying
from MRSA-infections in the US almost outnumbers those dying
from AIDS, tuberculosis, and viral hepatitis combined [1]. The
consequence is not only an enormous rise of health care costs, but
also a significantly higher mortality.
Enterococci are currently the second most common cause of
nosocomial infections in the US [2]. In Europe, incidences of
vancomycin-resistant enterococcal infections are increasing too
[3]. Enterococcus faecalis is the third most common cause of
prosthetic valve endocarditis [4] and despite steadily improved
antibiotic strategies the incidence of bacterial endocarditis
remained stable throughout the last 40 years.
The ability to produce biofilm plays a crucial role in foreign
body infections, such as prosthetic valve endocarditis [5–9].
Nevertheless, the underlying mechanisms of biofilm formation and
maintenance still need to be further investigated [5,9], especially in
enterococcus where these mechanisms have not been studied as
extensively as in staphylococci [10].
Mutants of enterococcal strains with a reduced ability to
produce biofilm have been studied previously by several investi-
gators [10] and in vivo bacteremia [11], endocarditis [12] and
urinary tract infection models [13] could confirm the reduced
pathogenicity of those strains.
In the present study we specifically studied two deletion mutants
of E. faecalis 12030 unable to produce bacterial glycolipids
regarding their ability to cause native valve endocarditis in a rat
endocarditis model. The deletion mutants were deficient for
glucosyltransferases referred to as biofilm-associated glycolipid
synthesis A (DbgsA) and biofilm-associated glycolipid synthesis B
(DbgsB), respectively. Both enzymes play a crucial role in the
biosynthesis of Diglycosyl-diacylglycerol (DGlcDAG) showing
accumulation of Monoglycosyl-diacylglycerol (MGlcDAG) in
DbgsA and a complete loss of glycolipids in DbgsB, as reported
previously by Theilacker et al. [11,14]. Our previous results
demonstrated that elimination of glycolipid synthesis results in a
reduced accumulation of biofilm mass rather than in impaired
adherence itself [11]. Adhesion of enterococci to colon carcinoma
cell-line Caco2 was specifically inhibited by up to 47% through the
addition of DGlcDAG, suggesting a role of glycolipids in cellular
adherence to gastrointestinal epithelia [15]. To assess if this
mechanism is also operative in native valve endocarditis we
compared theses mutants with the wild type strain using a rat
endocarditis model.
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Materials and Methods
Bacterial strains and growth conditions
The different bacterial strains used are summarized in Table 1.
Enterococci were grown at 37uC without agitation in tryptic soy
broth (TSB; Carl Roth).
Deletion mutant EF2891 (12030DbgsA) and EF2890
(12030DbgsB)
The deletion mutants were derived from a strong biofilm-
forming wild-type strain E. faecalis 12030 (12030 wt) [16,17]. The
mutant strains are non-polar deletion mutants in the biofilm-
associated glycolipid synthesis A and B gene. Mutations were
created by targeted mutagenesis and deletion of an internal
fragment of 863 bp (12030DbgsA) [14] and 790 bp (12030DbgsB)
as described previously [11,14]. The deletion of bgsA leads to an
altered synthesis of cell wall glycolipids lacking diglucosyl–
diacylglycerol and overproducing monoglucosyl–diacylglycerol
while deletion of bgsB leads to a complete loss of cell membrane
glycolipids and an altered expression of lipoteichoic acids. Figure 1
shows the organization of the bgs-locus and the putative
biosynthetic pathway of glycolipid synthesis [11].
Preparation of inoculum
A dose-response relationship for the colonization of the
vegetations was determined for the wild-type strain to ensure a
reproducible and comparable bacterial inoculum. Based on
preliminary results, we chose inoculation doses between 1–
2*106 cfu per animal, which led to a reliable transient bacteremia
of at least 24 h. To determine absolute values of inoculated
bacteria and to compare different inocula, serial dilution and cfu
counts of the inocula were done.
Rat model of endocarditis
The rat model of endocarditis is based on experimental findings
of colonization of non-bacterial thrombotic endocarditis in rabbits
by Durack and Beeson in 1972 [18]. This technique was then
transferred to a rat model in 1978 by Santoro and Levision [19].
Female Wistar rats (Charles River Laboratories Germany
GmbH), weighing 200 to 300 g were used. The animals were
anesthetized by subcutaneous application of 5.75% ketamine and
0.2% xylazine. Nonbacterial thrombotic endocarditis was caused
by insertion of a small plastic catheter (polyethylene tubing;
Intramedic PE 10) via the right carotid artery (Figure 2). The
artery was accessed by cutting the neck laterally on the right side.
The carotid artery could be easily exposed and ligated distally.
The polyethylene catheter was introduced via a small incision of
the vessel and advanced until a slight resistance indicated passage
through the aortic valve. The catheter was advanced through the
aortic valve into the left ventricle. Proper placement was ensured
via invasive pressure measurement through the catheter’s lumen.
To minimize confounding factors we focused on standardization of
the catheter insertion and its positioning. Preliminary experiments
without secondary bacterial colonization showed that pressure
monitoring and therewith objectification of catheter positioning
could minimize overly traumatic injury (which may lead to
pronounced thrombotic lesions) and ensured constant lesions. The
catheter was secured in place and distally ligated. A simple
running suture was used for wound closure. Postoperatively the
rats were returned to their cage and monitored closely.
Inoculation of bacteria followed 48 h after catheter placement
via injection into the tail vein. Ten rats per study group were
randomly assigned to two groups, one receiving the wild-type
strain 12030 wt, and the other being challenged with the deletion
mutant 12030DbgsA. In a separate series (n = 10) groups were
divided using 12030wt and 12030DbgsB respectively. Animals
were sacrificed on postoperative day 6 and the correct placement
of the catheter was verified. The extent of native valve endocarditis
was assessed and graded macroscopically with an objective grading
system as outlined in table 2. Subsequently valve vegetations were
Table 1. Bacterial strains.
Bacterial strain Description Reference
E. faecalis 12030 clinical isolate [16]
12030DbgsA deletion mutant in glycosyltransferase EF2891, no DGlcDAG [14]
12030DbgsB deletion mutant in glycosyltransferase EF2890, no glycolipids [11]
doi:10.1371/journal.pone.0091863.t001
Figure 1. Genetic organization of the bgs-locus and biosyn-
thetic pathway of glycolipid synthesis.
doi:10.1371/journal.pone.0091863.g001
Figure 2. Intraoperative view with catheter placed in the right
carotid artery.
doi:10.1371/journal.pone.0091863.g002
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removed aseptically. After weighing of the vegetations, 500 mL
TSB was added per sample and the vegetations were homogenized
on ice using a tissue homogenizer. The homogenizer was cleaned
with ethanol and flamed after each homogenization. Serial
dilutions of the samples were made in TSB and plated.
Quantitative assessment was performed by weighing of the
vegetations as well as culturing serial dilutions on agar plates
incubated over night at 37uC.
Statistical analysis
Comparisons of groups were performed using IBM SPSS
Statistics Desktop 20.0 and GraphPad Prism 5.04 for Microsoft
Windows. The primary evaluation criterion was the bacterial
count in the vegetation (cfu per gram and per ml, respectively).
The mean and standard deviation was calculated for each group.
Statistical significance was determined by Mann-Whitney U test.
Ethics statement
All animal experiments were performed with permission of the
regional administrative authority Freiburg (animal welfare com-
mittee of the University of Freiburg; Regierungspräsidium
Freiburg Az 35/9185.81/G-07/72) and in accordance with the
German animal protection law (TierSchG). The rats were handled
in accordance with good animal practice as defined by FELASA
and the national animal welfare body GV-SOLAS.
Results
Comparison of 12030wt with 12030DbgsA and with
12030DbgsB
Mutant 12030DbgsA showed a significantly reduced rate of
endocarditis (figure 3) compared to wild-type bacteria. The
inocula used had effective concentrations of 1.2256106 cfu/ml
for 12030 wt and 2.3256106 cfu/ml for 12030DbgsA.
One rat of the wild-type group died of unknown cause directly
after catheter placement. Therefore 12030 wt vs. 12030DbgsA
groups finally consisted of 4 rats infected with E. faecalis 12030 wt
and 5 rats infected with E. faecalis 12030DbgsA. Rats infected
with 12030DbgsA showed considerably but insignificantly less
severe endocarditic lesions macroscopically (p,0.39; table 3).
Bacterial vegetations of 12030DbgsA contained significantly less
CFU per milliliter and per gram compared to those formed by
12030 wt using the Mann–Whitney U test. The average colony
count for rats infected by 12030 wt and 12030DbgsA respectively
were 2.556101061.3761010 and 1.82610962.336109 CFU/gr,
p,0,016 (figure 3).
Mutant 12030DbgsB also showed a significantly reduced rate of
endocarditis compared to wild-type bacteria (Figure 4). The final
inocula used in this experiment showed 2.16106 cfu/ml for
12030 wt and 1.826106 cfu/ml for 12030DbgsB. Again one rat of
the wild-type group died during placement of the catheter. Thus
the wild-type group consisted of 4 rats whereas the 12030DbgsB
group counted 5 rats. Endocarditic lesions were graded macro-
scopically and showed significantly less severe vegetations in rats
challenged with 12030DbgsB compared to rats inoculated with
12030 wt (p,0.39; table 4). Bacterial vegetations of 12030DbgsB
contained less CFU compared to those by 12030 wt. Statistical
significance was tested using the Mann–Whitney U test. The
average colony count in rats infected with 12030 wt and
12030DbgsB respectively were 5.16610965.726109 and
2.24610764.936107 CFU/gr, p,0.016 (figure 4).
Table 2. Macroscopic grading system.
grading description
1 no visible deposits on valve
2 isolated deposits on valve, but unclear if thrombotic or endocarditic in nature
3 isolated endocarditic vegetations
4 multiple scattered endocarditic vegetations
5 confluent endocarditic vegetations covering the valve leaflets
6 bold endocarditic vegetations covering valve apparatus without further extent
7 vegetations on valve with circumscribed extent
8 fulminant vegetations on valve, further extension into left ventricular outflow tract and aortic root restricted to catheter
9 fulminant vegetations on valve extending into left ventricular outflow tract and aortic root
10 fulminant vegetations on valve extending into left ventricular outflow tract and aortic root and involvement of ventricular endocardium
doi:10.1371/journal.pone.0091863.t002
Figure 3. Comparison of virulence of wild type and
12030DbgsA specified by CFU/gr (bar indicates median).
doi:10.1371/journal.pone.0091863.g003
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Discussion
Enterococcal infections are an increasing clinical problem
worldwide [2]. While enterococci certainly are not as virulent as
other gram-positive cocci (such as Staphylococcus aureus or Streptococ-
cus pyogenes), they often exhibit broad-spectrum resistance to
antimicrobials, are able to acquire antibiotic resistance traits via
elaborate molecular mechanisms, and are able to resist harsh
environmental conditions [20]. Biofilm formation has been shown
to play a crucial role, especially in endocarditic lesions and
catheter-associated infections [21]. A variety of biofilm-associated
genes have been described in enterococci, encoding adhesins,
autolysins, polysaccharides, glycolipids and other molecules, each
of these causing virulence in specific settings [10].
The deletion mutant 12030DbgsA is characterized by a loss of
the major bacterial glycolipid DGlcDAG and by an accumulation
of its precursor, MGlcDAG. Mutant 12030DbgsB completely lacks
glycolipids in its cell wall. In a rat model of infective endocarditis
we could demonstrate that these two different enterococcal
deletion mutants with their altered biofilm formation capabilities
produced less endocarditic lesions when compared to the wild
type. Despite slightly higher bacterial inocula for the mutant
strains, the colony counts in vegetations were significantly reduced
both for 12030DbgsA as well as for 12030DbgsB compared to the
wild type. We have previously shown that the replacement of
DGlcDAG with MGlcDAG leads to a significantly impaired
biofilm production in vitro (i.e. on polystyrene plates and colon
epithelial cells) and in vivo in a mouse sepsis model [11,14]. On
the other hand, cell morphology, autolysis, growth rate or
expression of cell wall-associated proteins were not altered in
these mutants [11,14]. The role of glycolipids in vivo has already
been assessed in mouse bacteremia models and a reduced
persistence of bacteria in blood, liver, kidneys and spleens has
been documented [11,14]. However, these models do not
represent typical biofilm infections.
Certainly our results have to be interpreted cautiously. First of
all the small sample size weakens the results with regard to
statistical power, although our experience with this model of
infective endocarditis taught us that results are reproducible.
Furthermore the extent of non-infective thrombotic endocarditis
plays a crucial role in the secondary bacterial colonization. To
ensure constant non-infective lesions, we assessed the proper
placement of the catheter and assessed the lesions themselves in
preliminary tests.
Since we did not measure blood stream survival of the
inoculated bacteria, the influence of direct bloodstream clearance
or the increased sensitivity of the mutants to the innate immune
functions of the animals cannot be differentiated. Nevertheless
previous data from our group show that the deletion of
glucosyltransferase bgsB has no effect on resistance to comple-
ment, antimicrobial peptides, and opsonophagocytic killing [11].
The bgsA deletion mutant showed higher susceptibility to
opsonophagocytic killing, but comparable sensitivity to comple-
Table 3. Macroscopic grading and absolute weight of
vegetation of endocarditic lesions of 12030 wt and
12030DbgsB, showing insignificantly higher grades (p,0.39)
and weights in the wild type (p,0.35).
No. strain macroscopic grade weight of vegetation (mg)
1 12030 wt 7/10 3,56
2 12030 wt 7/10 3,35
3 12030 wt 8/10 9,54
4 12030 wt 3/10 1,59
5 12030 wt { {
6 12030DbgsA 2/10 0,40
7 12030DbgsA 8/10 3,25
8 12030DbgsA 5/10 2,60
9 12030DbgsA 4/10 3,35
10 12030DbgsA 5/10 1,42
doi:10.1371/journal.pone.0091863.t003
Figure 4. Comparison of virulence of . wild type and
12030DbgsB specified by CFU/gr (bar indicates median).
doi:10.1371/journal.pone.0091863.g004
Table 4. Macroscopic grading and absolute weight of
vegetation of endocarditic lesions of 12030 wt and
12030DbgsB, showing significantly higher grades (p,0.05)
and weights in the wild type (p,0.05).
No. strain macroscopic grade weight of vegetation (mg)
1 12030 wt 9/10 9,76
2 12030 wt 7/10 5,14
3 12030 wt 5/10 3,7
4 12030 wt 7/10 8,93
5 12030 wt { {
6 12030DbgsB 1/10 0,44
7 12030DbgsB 1/10 1,04
8 12030DbgsB 2/10 0,58
9 12030DbgsB 1/10 0,78
10 12030DbgsB 2/10 0,71
doi:10.1371/journal.pone.0091863.t004
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ment-mediated killing [14]. Although the significantly reduced
endocarditic lesions might be a direct effect of impaired biofilm
accumulation on the heart valve itself our results cannot clarify if
the reduced virulence of the mutant strains is caused by interaction
with host defense instead.
In addition we could identify a putative virulence factor for
enterococcal endocarditis, which might offer new therapeutic
approaches. Guo et al. for example reported the use of antisense
oligodeoxyribonucleotides as a way of gene silencing in Streptococcus
mutants as a novel approach to decrease biofilm formation [22].
Specific small molecule inhibitors of genes essential for virulence
but not directly toxic for bacteria may exert less selective pressure
to develop resistances and may be therefore attractive novel
therapeutic approaches [23]. Our results indicate that the model
presented here is suitable to assess specific virulence factors of
enterococcal strains involved in biofilm infections. This will allow
the detection and confirmation of additional virulence factors and
may lead to the development of novel therapeutic approaches.
Further studies are needed to differentiate the factors influencing
the formation of bacterial endocarditis in biofilm deficient mutants
of enterococci.
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